Viewing Study NCT06305234


Ignite Creation Date: 2025-12-25 @ 2:22 AM
Ignite Modification Date: 2025-12-27 @ 11:00 PM
Study NCT ID: NCT06305234
Status: RECRUITING
Last Update Posted: 2024-08-26
First Post: 2024-01-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Long Term, Post-marketing Study of Immune Response in Patients Receiving Palynziq Treatment for PKU (PALisade)
Sponsor: BioMarin Pharmaceutical
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module